Pure Global

Multiple immunocompromised host infection-associated virus nucleic acid IVD, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Multiple immunocompromised host infection-associated virus nucleic acid IVD, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 148437. The device is manufactured by 3B BlackBio Biotech India Limited (a subsidiary of Kilpest India Limited) from India, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Wellkang Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Multiple immunocompromised host infection-associated virus nucleic acid IVD, nucleic acid technique (NAT)
MHRA Device ID: 148437โ€ขRef: 148437

Device Type

In Vitro Diagnostic Device

Devices

Multiple immunocompromised host infection-associated virus nucleic acid IVD, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Feb 9, 2024

Manufacturer Information

Address

7-C, Industrial Area Govindpura Bhopal

Bhopal, India

Created Date

May 13, 2022

Authorized Representative

Relationship Type

UK Responsible Person

Address

16 Castle St.

Dover, Kent, England, United Kingdom

Postcode: CT16 1PW

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing